SEC Form 4 · accession 0001562180-18-003703
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dana G Mead Jr.
Director
Period of report
Aug 6, 2018
Accepted (ET)
Aug 17, 2018 · 7:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 6, 2018 | P | 3,811 | $26.2247 | A | 13,567 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.075 to $26.30, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares purchase at each separate price within the ranges set forth in this footnote to this Form 4.
- F2Includes 1,514 Restricted Stock Units.